These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31876822)

  • 1. 99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and Intraobserver Variability in Treatment-Related Longitudinal Tracer Uptake Assessments of Prostate-Specific Membrane Antigen-Positive Lesions.
    Schmidkonz C; Atzinger A; Goetz TI; Beck M; Ritt P; Prante O; Kuwert T; Bäuerle T; Cordes M
    Clin Nucl Med; 2020 Feb; 45(2):105-112. PubMed ID: 31876822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMA SPECT/CT with
    Schmidkonz C; Goetz TI; Kuwert T; Ritt P; Prante O; Bäuerle T; Goebell P; Cordes M
    Ann Nucl Med; 2019 Dec; 33(12):891-898. PubMed ID: 31502084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer.
    Schmidkonz C; Cordes M; Beck M; Goetz TI; Schmidt D; Prante O; Bäuerle T; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Clin Nucl Med; 2018 Apr; 43(4):225-231. PubMed ID: 29401151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual Comparison of
    Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Schmidkonz C; Hollweg C; Beck M; Reinfelder J; Goetz TI; Sanders JC; Schmidt D; Prante O; Bäuerle T; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Prostate; 2018 Jan; 78(1):54-63. PubMed ID: 29105797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate Cancer.
    Schmidkonz C; Götz TI; Atzinger A; Ritt P; Prante O; Kuwert T; Bäuerle T; Goebell P; Cordes M
    Clin Nucl Med; 2020 Aug; 45(8):e349-e357. PubMed ID: 32558706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.
    Singh B; Sharma S; Bansal P; Hooda M; Singh H; Parihar AS; Kumar A; Watts A; Mohan R; Singh SK
    Nucl Med Commun; 2021 May; 42(5):482-489. PubMed ID: 33395191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer.
    Reinfelder J; Kuwert T; Beck M; Sanders JC; Ritt P; Schmidkonz C; Hennig P; Prante O; Uder M; Wullich B; Goebell P
    Clin Nucl Med; 2017 Jan; 42(1):26-33. PubMed ID: 27775936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial experiences with
    Farkas I; Besenyi Z; Maráz A; Bajory Z; Palkó A; Sipka G; Pávics L
    Orv Hetil; 2018 Sep; 159(35):1433-1440. PubMed ID: 30146905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen: pharmacokinetics and biodistribution studies in healthy subjects and patients with metastatic prostate cancer.
    Vallabhajosula S; Nikolopoulou A; Babich JW; Osborne JR; Tagawa ST; Lipai I; Solnes L; Maresca KP; Armor T; Joyal JL; Crummet R; Stubbs JB; Goldsmith SJ
    J Nucl Med; 2014 Nov; 55(11):1791-8. PubMed ID: 25342385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation Dosimetry of
    Urbán S; Meyer C; Dahlbom M; Farkas I; Sipka G; Besenyi Z; Czernin J; Calais J; Pávics L
    J Nucl Med; 2021 Aug; 62(8):1075-1081. PubMed ID: 33277398
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer.
    Schmidkonz C; Cordes M; Beck M; Goetz TI; Schmidt D; Prante O; Bäuerle T; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Clin Nucl Med; 2018 Aug; 43(8):e250-e258. PubMed ID: 29916921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing PSMA scintigraphy for resource limited settings - a retrospective comparative study.
    Kolade OU; Brink A; Ayeni AO; More S; Holness J
    Cancer Imaging; 2024 Apr; 24(1):46. PubMed ID: 38556864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
    Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
    Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
    Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
    J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT-CT Imaging with [99mTc]PSMA-T4 in patients with Recurrent Prostate Cancer.
    Sergieva S; Mangaldgiev R; Dimcheva M; Nedev K; Zahariev Z; Robev B
    Nucl Med Rev Cent East Eur; 2021; 24(2):70-81. PubMed ID: 34382671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-PSMA-I&T-PET/CT interobserver and intraobserver agreement for prostate cancer: a lesion based and subregional comparison study among observers with different levels of experience.
    Soyluoglu S; Korkmaz U; Ozdemir B; Ustun F; Durmus-Altun G
    Nucl Med Commun; 2021 Oct; 42(10):1122-1129. PubMed ID: 34001829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
    Kabasakal L; Demirci E; Ocak M; Akyel R; Nematyazar J; Aygun A; Halac M; Talat Z; Araman A
    Nucl Med Commun; 2015 Jun; 36(6):582-7. PubMed ID: 25738559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Bone Uptake in Bone Scan and Ga-68 PSMA PET/CT Images in Patients with Prostate Cancer.
    Acar E; Bekiş R; Polack B
    Curr Med Imaging Rev; 2019; 15(6):589-594. PubMed ID: 32008568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
    Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
    Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.